Roeland Nusse Power - 25 Aug 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Reporting relationship
Director
Issuer ticker
TECH
Reported as of
25 Aug 2025
Net transaction value
-$588,234
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Aug 2025, 16:10:21 UTC
Prior SEC filing
28 Oct 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Andrew Nick as Attorney-in-Fact for Roeland Nusse pursuant to Power of Attorney previously filed

Key filing fact

Roeland Nusse Power filed Form 4 for BIO-TECHNE Corp (TECH) on 27 Aug 2025.

Key facts

  • This page summarizes Roeland Nusse Power's Form 4 filing for BIO-TECHNE Corp (TECH).
  • 3 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 27 Aug 2025, 16:10.

Change

  • Previous filing in this sequence was filed on 28 Oct 2024.
  • Current net transaction value: -$588,234.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001492695 Primary reporting owner

Nusse Roeland

Relationship
Director
Address
614 MCKINLEY PL NE, MINNEAPOLIS
Signature
Andrew Nick as Attorney-in-Fact for Roeland Nusse pursuant to Power of Attorney previously filed
Signature date
27 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TECH transaction

Common Stock

Options Exercise

Transaction value
$372,154
Shares
+17,040
Change %
+38%
Price
$21.84
Shares after
61,599
Date
25 Aug 2025
Ownership
Direct
TECH transaction

Common Stock

Sale

Transaction value
$960,388
Shares
-17,040
Change %
-28%
Price
$56.36
Shares after
44,559
Date
25 Aug 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TECH transaction Derivative

Stock Options (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-17,040
Change %
-100%
Price
$0.000000
Shares after
0
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,040
Exercise price
$21.84
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,940
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,940
Exercise price
$25.30
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
12,500
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,500
Exercise price
$31.26
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,592
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,592
Exercise price
$44.96
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,044
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,044
Exercise price
$50.41
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,028
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,028
Exercise price
$63.92
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,532
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,532
Exercise price
$128.81
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,460
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,460
Exercise price
$73.94
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,937
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,937
Exercise price
$61.51
TECH holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,511
Date
25 Aug 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,511
Exercise price
$68.37
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.21 to $56.33 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F2

The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .